NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

A DOAC Deep Dive: Betrixaban

For the past several decades, warfarin has been the go-to anticoagulant for doctors, but new treatments have recently emerged in the…

Clot Chronicles: 2018 NATF Summit

Dr. Sam Goldhaber discusses the upcoming 2018 NATF Summit and the importance of understanding the connection between diabetes, metabolic syndrome,…

Recent Updates in VTE Treatment

Sam Schulman, MD, PhD, speaks on the latest updates in VTE treatment. From the 19th Annual Antithrombotic Therapy Symposium, Wayne…

Important and Impactful Papers of 2017

Scott Kaatz, DO, explores the most impactful research of 2017. From the 19th Annual Antithrombotic Therapy Symposium, Wayne State University

Preventing VTE After Hospitalization

Umberto Campia, MD, MS discusses prevention of venous thromboembolism after a patient has been released from the hospital. This presentation…